Wikidata

(Q45904176)

English

Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials.

scientific article published on 5 February 2014

In more languages

Statements

title
Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24509273
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24509273%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45904176&oldid=1647906885"